Chipmakers and Miners Rewrite Rules: FEIM's 70% Surge, Pebble Mine Verdict LoomsGlobal Report·Sep 29 at 09:15 AMNAK-0.75%QNTM+0.44%
Quantum BioPharma (NASDAQ: QNTM) Receives FDA Green Light to Move Lucid-MS into Phase 2 Testingbusinessinsider·Sep 25 at 03:35 PMQNTM+0.44%
Quantum BioPharma (NASDAQ: QNTM) Pursues a New Path for Better Multiple Sclerosis Treatmentsbusinessinsider·Sep 23 at 06:05 PMQNTM+0.44%
Quantum BioPharma Highlights Year of Financing Moves, Debt Settlement and Governance ChangesTip Ranks·Sep 17 at 07:27 PMQNTM+0.44%
Quantum BioPharma board authorizes Class A multiple-voting share offering to lift control stake to 75.27%PUBT·Sep 17 at 07:13 PMQNTM+0.44%
Quantum BioPharma grants 7,692 stock options to director Zapolin at C$ 6.6 per sharePUBT·Sep 17 at 07:13 PMQNTM+0.44%
Quantum BioPharma Gains Rodman & Renshaw BUY Rating and US$8 TargetTip Ranks·Sep 17 at 12:27 PMQNTM+0.44%
Rodman & Renshaw initiates Quantum BioPharma coverage with buy rating, US$ 8 targetPUBT·Sep 17 at 12:01 PMQNTM+0.44%
Quantum BioPharma Showcases FDA-Backed Lucid-MS Program at Toronto Growth SummitTip Ranks·Sep 15 at 12:32 PMQNTM+0.44%
